OBEROTATUG RAVTANSINE
UNII N2Q7V645PL

Substance Identification & Data

This profile provides standardized clinical and technical data for Oberotatug Ravtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N2Q7V645PL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2641919-35-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N2Q7V645PL

CAS Registry Number

2641919-35-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OBEROTATUG RAVTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199080

National Cancer Institute reference terminology for clinical and research data.

INN ID

12296

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-68

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oberotatug Ravtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OBEROTATUG RAVTANSINE

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS LY75 (HUMAN LYMPHOCYTE ANTIGEN 75, C-TYPE LECTIN DOMAIN FAMILY 13 MEMBER B, CLEC13B, DEC-205, CD205)), HOMO SAPIENS MONOCLONAL ANTIBODY; CONJUGATED TO RAVTANSINE

OBEROTATUG RAVTANSINE [INN]

OBEROTATUG RAVTANSINE [USAN]